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Human keratinocytes are known to kill Candida albi-
cans in vitro, but the mechanism of killing is not yet
understood. Here, we demonstrate that spontaneous,
ultraviolet-B-light-induced, a-melanocyte-stimulat-
ing-hormone-induced, and interleukin-8-induced
Candida killing by keratinocytes can be inhibited with
mannan and mannosylated bovine serum albumin
(Man-BSA). A polyclonal goat serum raised against
the human macrophage mannose receptor stained
suprabasal keratinocytes, but no staining was
observed on keratinocytes with a monoclonal anti-
body (mAb15) speci®c for the human macrophage
mannose receptor. Mannose-af®nity chromatography
of keratinocyte extract isolated a 200 kDa protein,
and on the Western blot the goat antiserum reacted
with a 200 kDa protein. In radioligand binding
studies, the binding of 125I-Man-BSA to human kera-
tinocytes was inhibited by mannan in a concentra-
tion-dependent manner. Analysis of the binding
revealed a single class keratinocyte mannose receptor
with a KD of 1.4 3 10
±8 M and a Bmax of 1 3 10
4
binding sites per cell. The binding of 125I-Man-
BSA to keratinocytes proved to be time-dependent,
acid-precipitable, and Ca2+- and trypsin-sensitive.
After trypsinization the receptors underwent a rapid
recovery at 37°C. These results demonstrate the pres-
ence of mannose receptor on human keratinocytes,
and its active involvement in the killing of Candida
albicans. Key words: antimicrobial activity/Candida infec-
tion/epidermis/skin. J Invest Dermatol 117:205±213, 2001
I
n both experimental and naturally occurring cutaneous
Candida albicans infections, the infecting Candida albicans
organisms are con®ned to the upper portion of the
epidermis (Kirkpatrick et al, 1971; Scherwitz, 1982;
Sohnle and Hahn, 1992). Deep or systemic Candida
infections are rare in patients with chronic mucocutaneous
candidiasis, despite extensive super®cial infections (Ray and
Wuepper, 1978; Kauffman et al, 1981). The formation of
neutrophilic in®ltrates in the epidermis and epidermal hyperpro-
liferation are characteristic cutaneous changes in Candida albicans
infections of the skin. Each of these cutaneous responses has been
suggested to be important for the defense against super®cial fungal
infections (Sohnle and Kirkpatrick, 1978; Sohnle and Hahn, 1989).
Although polymorphonuclear (PMN) leukocytes easily phago-
cytize Candida albicans in vitro, ultrastructural examination of
Candida-infected skin failed to show fungal elements in regions
of microabscesses (Scherwitz, 1982). On the other hand, in that
same study, the majority of the fungal cells were found among
epithelial cells of the stratum corneum and they could not be
detected in noncorni®ed cells of the malphigian layer. In a more
recent investigation using cyclophosphamide-treated mice it was
shown that even in the absence of epidermal neutrophil in®ltrates
Candida albicans is con®ned to the epidermis. Removal of the
epidermis by scraping prior to inoculation with the yeast, however,
resulted in Candida pseudohyphae invasion of the dermis,
indicating that suprabasal keratinocytes may play a role in the
defense against cutaneous Candida infection (Hahn and Sohnle,
1988). Vaginal epithelial cells of both rodents and macaques have
recently been shown to be predominantly responsible for innate
immunity against yeast cell colonization (Steele et al, 1999a, b).
In previous work we have shown that epidermal cells have direct
candidacidal activity and this activity can be increased through
stimulation of epidermal cells with ultraviolet (UV) light (Csato
et al, 1986, 1987), a-melanocyte stimulating hormone (a-MSH)
(Csato et al, 1989), and interleukin-8 (IL-8).1 IL-1, prostaglandin E2
(PGE2), and platelet-activating factor have also been demonstrated
to be involved in Candida killing by human epidermal cells (Csato
et al, 1990), but the mechanism of killing remains unknown.
Mononuclear phagocytes are believed to play an important role
in combating fungal infections. Optimal phagocytosis of Candida
albicans requires opsonization, but unopsonized yeast can also be
internalized by macrophages through the mannose receptor
(Karbassi et al, 1987). The major components of the cell wall of
Candida are mannan (an a-linked polymer of mannose), glucan (a
b-linked branched chain polysaccharide of glucose), and chitin (a
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cellulose-like biopolymer consisting predominantly of N-acetyl-D-
glucosamine) (Cassone, 1989). The macrophage mannose receptor
(MMR) recognizes carbohydrates expressed on the surfaces of
microorganisms and is particularly well suited to direct particles to
phagolysosomes and trigger a respiratory burst (Marodi et al, 1993).
It has been shown that human keratinocytic cells from squamous
carcinoma (SCL-1) and multiply passaged cultured keratinocytes
from normal skin express sugar-binding proteins on their surface
(Cerdan et al, 1991; Condaminet et al, 1997). Human keratinocytes
also possess the ability to synthesize and express cell surface moieties
characteristic of effector and/or accessory cells of the immune
system (Hunyadi et al, 1992; 1993). Here, we demonstrate the
presence of mannose-binding receptors on normal human
keratinocytes and provide data indicating their involvement in
the killing of Candida. The keratinocyte mannose-binding receptor
(KcMR), isolated by mannose-af®nity chromatography, has a
different molecular mass (200 kDa) from that of MMR (175 kDa).
The fact that the KcMR differs from the MMR is also indicated by
the absence of cross-reactivity to a monoclonal MMR antibody
(mAb15). At the same time, a goat immune serum raised against the
human MMR cross-reacts with KcMR, showing membrane
staining of suprabasally localized cells on skin sections. The same
goat antiserum also reacted with a band of 200 kDa on the Western
blot of keratinocyte extracts. The KcMR resembles the MMR in
that it is Ca2+-dependent, sensitive to proteolysis, and has a KD of
1.4 3 10±8 M and a Bmax of 10
4 per cell, but unlike the MMR it
does not internalize mannose ef®ciently.
MATERIALS AND METHODS
Cells Human epidermal cells were obtained from healthy individuals
undergoing plastic surgery after they had given their informed consent in
conformity with the requirements of the Institutional Review Board of
the Albert Szent-GyoÈrgyi Medical Center, University of Szeged. After
removal of the subcutaneous tissue and much of the reticular dermis, the
tissue samples were cut into small strips and incubated with 0.25%
trypsin (Sigma, Budapest, Hungary) overnight at 4°C. Subsequently, the
epidermis was peeled off from the dermis. Dissociation of the epidermal
layer into a single cell suspension was accomplished by gentle aspiration
with a Pasteur pipette. The cell suspension was ®ltered through a 100
mm cell ®lter (BioDesign of New York, Carmel, NY). A suspension of
single cells (106) was prepared in Dulbecco's modi®ed Eagle's medium
(DMEM) (Gibco, Eggenstein, Germany) supplemented with 20% fetal
bovine serum, 20 mM HEPES buffer, 100 U per ml penicillin, and 100
mg per ml streptomycin (each from Gibco). The viability of the cells was
always >85%, as determined by trypan blue exclusion. The separated
cells were characterized by immunohistochemistry on cytospin prepar-
ations (Cytospin, Shandon-Elliot, Frankfurt, Germany). Keratinocytes
were labeled with the monoclonal antibody Lu 5 (Boehringer Mannheim
Biochemicals, Mannheim, Germany), which reacts with an epitope
common to all cytokeratins (1±19); Langerhans cells were labeled with
anti-CD1a antibody (Boehringer); and endothelial cells were labeled with
the monoclonal antibody BMA 120 (Behring Werke, Marburg,
Germany), which reacts with a 200 kDa antigen that is different from
the von Willebrand factor molecule but is also highly speci®c for
endothelial cells (Alles and Bosslet, 1988). Fibroblasts and melanocytes
were identi®ed with anti-vimentin antibody (Boehringer) (Arenberger
et al, 1993). Immunohistochemical analyses of the separated cells
demonstrated that over 95% were keratinocytes; the rest were
contaminating ®broblasts and melanocytes; no endothelial or Langerhans
cells were detected.
Candida albicans (0656 CBS Delft) was cultured on Sabouraud agar and
transferred onto fresh agar 24 h prior to the killing assay. Candida cells
were harvested with phosphate-buffered saline (PBS) and counted in a
hemocytometer. Under these conditions suf®cient numbers of Candida
cells can be obtained without germ tubes and hyphae. Their viability was
checked with trypan blue.
For the adherence assay, Candida albicans cells were resuspended in
PBS at a ®nal concentration of 107 blastospore cells per ml and then
®xed with 70% ethanol for 1 h at room temperature and washed twice
in PBS. The Candida cells were next incubated with 0.1 mg per ml
¯uorescein isothiocyanate (FITC) (Sigma, Budapest) in a 0.5 M
carbonate/bicarbonate buffer (pH 9.5) for 30 min on a moving plate in
the dark and ®nally washed ®ve times in PBS (Sarasella et al, 1997).
Human PMN leukocytes were isolated from venous blood, freshly
drawn from healthy donors after obtaining their informed consent in
accordance with the requirements of the Institutional Review Board of
the Medical and Health Science Center, University of Debrecen, by
dextran sedimentation and centrifugation over Ficoll-Hypaque
(Pharmacia, Uppsala, Sweden), as previously described (Arenberger et al,
1993). Contaminating erythrocytes were lysed with hypotonic saline and
the PMN leukocytes were then washed with PBS and counted under a
microscope.
Killing assay A modi®ed method originally introduced for blood
leukocytes was employed to evaluate Candida killing by keratinocytes
(Csato et al, 1987). Brie¯y, 106 human keratinocytes and 2 3 106
Candida cells, or Candida alone in DMEM, were incubated for 4 h at
37°C in an atmosphere of 5% CO2 in a volume of 1 ml. After the
incubation period Triton X-100 (1%) (Sigma) was added to the mixture
and to the Candida control (Candida alone) for 5 min at 4°C in order to
lyse the keratinocytes. The Candida albicans cells were then stained with
methylene blue (0.1%) for 45 min at 4°C and the killed, non-viable
Candida cells were counted in a hemocytometer under the microscope.
The number of Candida killed by the keratinocytes was calculated by
subtracting the number of dead Candida cells in the control from the
number of dead Candida cells in the reaction mixture. The percentage of
non-viable Candida cells was de®ned as the killing activity. To ascertain
the accuracy of our methylene blue assay we also determined the colony
forming units (Marodi et al, 1991b; Sawyer et al, 1992) in parallel with
the Candida albicans cell counts in a separate experiment. A strong
correlation was found between the results of the two assays: r = 0.984,
p < 0.05.
In several experiments we used human PMN leukocytes to measure
their Candida killing activity. For the killing assay of PMN leukocytes,
Candida yeasts were opsonized with 2.5% normal human serum for 30
min prior to each assay and then washed with PBS. 106 leukocytes were
incubated with 2 3 106 opsonized Candida cells, or Candida alone in
DMEM was incubated for 30 min at 37°C in an atmosphere of 5% CO2
in a volume of 1 ml. After the incubation period, Triton X-100 (1%)
(Sigma) was added to the mixture and to the Candida control (Candida
alone) for 5 min at 4°C in order to lyse the granulocytes. The Candida
albicans cells were then stained with methylene blue (0.1%) for 45 min at
4°C and the killed, non-viable Candida cells were counted in a
hemocytometer under the microscope. The number of Candida cells
killed by the PMN leukocytes was calculated by subtracting the number
of dead Candida cells in the control from the number of dead Candida
cells in the reaction mixture. The percentage of non-viable Candida cells
was de®ned as the killing activity.
Modulation of Candida killing by UVB, a-MSH, and IL-
8 Keratinocytes in suspension were exposed to UV radiation up to 220
mJ per cm2 using a Saalman-SUP lamp (Gerhard Saalman, Herford,
Germany) with a spectrum of 290±330 nm without any speci®c ®ltration
subsequent to a 20 min warm-up period. Spectroradiometry was
employed to determine the spectral output before each experiment. The
viability of the cells after UV irradiation never dropped below 80%.
After UV exposure, keratinocytes were incubated in DMEM at 37°C at
5% CO2 for 3 h before use in the above-described Candida killing assay.
In other experiments keratinocytes were stimulated for 12 h with 2 3
10±8 M recombinant human IL-8 (Hermann Biermann, Bad Nauheim,
Germany) or with 20 mg per ml a-MSH (Sigma) for 1 h (37°C, 5%
CO2) prior to the killing assay.
Inhibition of Candida killing 100 or 500 mg per ml mannan (Sigma,
>99% pure) or mannosylated-BSA (Man-BSA) (E/Y Labs, San Mateo,
CA) or 300 mg per ml galactose-BSA (Gal-BSA) (Sigma) dissolved in
DMEM was added to a mixture of human keratinocytes and Candida
cells to investigate the inhibition of killing activity. To probe the
hypothesis that Man-BSA may interfere with the killing of Candida by
cells that do not express mannose-binding receptors, the killing of
Candida albicans by PMN leukocytes was studied in the presence or
absence of 1 mg per ml Man-BSA.
To examine a possible non-speci®c protective effect of mannan on
Candida albicans, making it more resistant to chemically induced cell
death, 5 3 105 yeast cells were pretreated with 3 mg per ml mannan for
120 min prior to incubation with the fungicide ciclopirox olamine
(Hoechst, Budapest, Hungary) in a concentration of 2.5 or 5 mg per ml
for 120 min in a ®nal volume of 1 ml PBS. Dead, non-viable Candida
cells were determined as described above.
Adherence assays In the adherence assay, 5 3 105 freshly separated
human keratinocytes were mixed with 2 3 106 FITC-conjugated
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Candida cells in a ®nal volume of 1 ml PBS and incubated for 120 min
on a rotator at 37°C. The cells were then examined by ¯uorescence
microscopy (Opton, Germany) and by ¯ow cytometric analysis using a
FACStar Plus Flow Cytometer (Becton Dickinson). Data were collected
by using a linear ampli®er for side scatter (SSC) and logarithmic
ampli®ers for forward scatter (FSC) and ¯uorescence intensity (FL1).
FSC/SSC proved to be ef®cient in discriminating between human
keratinocytes and Candida albicans cells, due to the substantial differences
in structure and size. To determine the extent of adherence, non-
adherent yeasts were gated out and the green ¯uorescence of the
keratinocytes was measured by using the FL1 channel. This allows a
distinction of Candida-binding (FL1-positive) and non-binding FL1-
negative keratinocytes. Flow cytometric data (an average of 5 3 103
events) were analyzed by the Cell Quest 3.1 F software (Becton
Dickinson). To study the effect of mannan on the ability of keratinocytes
to bind Candida cells, keratinocytes were incubated with 3 mg per ml
mannan dissolved in PBS for 60 min before the adherence assay.
Immunohistology Skin biopsies were taken from disposed tissues of
healthy individuals undergoing plastic surgery operations. The samples
were embedded in cryomatrix (Shandon, Life Sciences International,
U.K.), 7 mm sections were cut and ®xed in acetone (10 min, 4°C), and
the sections were stained with a monoclonal antibody (mAb15) against
the human MMR (mouse IgG1) and with the goat antiserum against the
puri®ed human MMR (both kindly provided by Philip D. Stahl,
Washington University, St. Louis, MO).
The incubation step with the primary antibodies (1:50 dilutions) and
the appropriate controls (mouse IgG1, preimmune goat serum) for 60
min at room temperature was followed with incubation of biotin-
conjugated secondary antibodies, and then streptavidin±biotin peroxidase,
using the DAKO Strept ABC complex kit and its protocol (DAKO,
Denmark). 3-Amino-9-ethylcarbazole (AEC, Sigma) was used as a
peroxidase substrate. 2.5 ml AEC (4 mg AEC dissolved in 1 ml N,N-
dimethylformamide) was added to 17 ml 0.1 M acetate buffer (pH 5.2)
and 10 ml 30% H2O2. The sections were counterstained with hematox-
ylin.
Isolation of KcMR Freshly separated human keratinocytes were
collected from healthy individuals undergoing plastic surgery operations
as described above. 2.4 3 108 keratinocytes were homogenized with a
handheld Polytron homogenizer (Brinkmann Instruments, Westbury,
NY) in loading buffer containing 0.5% Triton X-100, 10 mM Tris-HCl
(pH 7.4), 1.25 M NaCl, 15 mM CaCl2, and 0.1 mM phenyl-
methylsulfonyl ¯uoride (PMSF) (all from Sigma). Debris was removed by
centrifugation (12,000g, 35 min). The receptor was bound to a mannose-
coupled epoxy-activated mannose±Sepharose 6B column (Pharmacia
Biotech, Uppsala, Sweden) in loading buffer and subsequently eluted
with the same buffer containing 0.1 M mannose. The partially puri®ed
mannose-binding protein was subjected to electrophoresis in 7.5%
polyacrylamide gel (PAGE) in sodium dodecyl sulfate (SDS) under non-
reducing conditions. Protein was visualized with silver staining
(Sammons et al, 1981).
Western blotting Protein extracts from freshly separated human
keratinocytes and the HaCaT human keratinocyte cell line (Boukamp
et al, 1988) were prepared in a lysis buffer of 1.5% SDS, 62.5 mM Tris-
HCl pH 6.8, 5 mM ethylenediamine tetraacetic acid, 5% 2-mercapto-
ethanol, 1 mg per ml PMSF, 1 mg per ml antipain, 1 mg per ml
chymostatin, and 1 mg per ml leupeptin (all from Sigma). Lysates were
centrifuged and supernatants were stored at ±20°C. The extracted
proteins of keratinocytes were separated by SDS-PAGE (with 9%
separating gel) and then transferred to nitrocellulose membrane (Protran
BA 83). Blots were blocked in Tris-buffered saline (150 mM NaCl, 25
mM Tris-HCl pH 7.4) containing 0.05% Tween-20 and 3% non-fat dry
milk (all from Sigma). Blots were incubated overnight at 4°C with a
1:200 dilution of goat antiserum for the human MMR. Alkaline
phosphatase conjugated mouse anti-goat immunoglobulin (Sigma) was
used as secondary antibody at a 1:4500 dilution for 2 h at room
temperature. Blots were developed by using 5-bromo-4-chloro-3-indolyl
phosphate/nitroblue tetrazolium substrate (Sigma).
Radioligand binding study Man-BSA was trace-labeled with 125I by
the chloramine T method (Salacinski et al, 1981). 5 3 105 keratinocytes
were incubated with increasing concentrations of 125I-Man-BSA (0.25±5
mg per ml, 1 3 106 cpm per mg) in DMEM containing 1% bovine
serum albumin (BSA), 10 mM HEPES, and 1.2 mM CaCl2 in a ®nal
volume of 400 ml. The incubation lasted for 90 min at 4°C under
continuous shaking, and was terminated by washing the cells twice with
ice-cold PBS. Cell-associated radioactivity was detected in a Packard
gamma-spectrometer (Packard Instrument, Downers Grove, IL).
Mannan-independent binding was determined in the presence of 3 mg
per ml unlabeled mannan. The mannan-speci®c binding was de®ned as
the difference between the total and the mannan-independent 125I-Man-
BSA binding (Sato and Beutler, 1993). Each assay was carried out in
duplicate in three separate experiments. For determination of the
dissociation constant (KD) and the number of binding sites per cell
(Bmax), saturation curves were analyzed with the computerized nonlinear
curve-®tting program MxN-FIT (BuÈrgisser, 1988).
In competition studies the cells were incubated with 0.15 mg per ml
125I-Man-BSA and with increasing concentrations of unlabeled ligand in
the range 10±3000 mg per ml. Competition studies were performed
under the same conditions as the saturation assays.
Internalization of 125I-Man-BSA Man-BSA was again trace-labeled
with 125I by the chloramine T method. To determine the kinetics of
internalization of 125I-Man-BSA, a modi®ed radioligand binding study
was performed at 37°C (Ezekowitz et al, 1981). Brie¯y, keratinocytes (5
3 105 per well) were incubated with 10 mg (1.0 3 106 cpm per mg)
125I-Man-BSA in the presence or absence of 3 mg per ml mannan in a
®nal volume of 400 ml. After different time intervals (10, 20, and 30
min), the binding was stopped by washing the cells four times with ice-
cold PBS, and the cell-bound radioactivity was measured with a gamma-
counter. The mannan-speci®c binding was de®ned as the total binding
minus the mannan-independent binding. To examine how much of the
cell-bound radioactivity was internalized, cells were treated for 3 min
with acetic acid (pH 3) and then washed twice with ice-cold PBS. The
acid-stable radioactivity represents internalized ligand, whereas the acid-
labile radioactivity is equivalent to surface-bound ligand (Arenberger et al,
1993).
Ca2+ and trypsin effects To determine the Ca2+ dependence of the
Man-BSA binding sites, the radioligand binding study was performed in
the presence of 10 mM ethylene glycol-bis(b-aminoethyl ether)-
N,N,N¢,N¢-tetraacetic acid (EGTA) (Sigma) at 37°C.
To investigate the trypsin sensitivity of the mannose-binding receptors,
cells were incubated with 10 mg per ml trypsin (type I from bovine
pancreas, Sigma) for 10, 60, or 120 min prior to the binding assay.
Flow cytometric detection of the KcMR 1 3 106 freshly separated
human keratinocytes were incubated with 100 ml goat anti-human
MMR antiserum dissolved in 0.5% BSA±PBS at a dilution of 1:25 for 1 h
on ice. For isotype control, non-immune goat serum was used. Cells
were washed twice in PBS and incubated for another 1 h on ice with
biotinylated mouse anti-goat IgG at 1:200 dilution. After washing again
twice in PBS cells were incubated with 100 ml streptavidin-PE (Becton
Dickinson, Heidelberg, Germany) at 1:100 dilution for 1 h on ice. The
cells were then ®xed in 1% paraformaldehyde and analyzed by ¯ow
cytometry using a FACStar Plus Flow Cytometer (Becton Dickinson).
Data (an average of 10,000 events per sample) were analyzed with the
Cell Quest 3.1 F program.
Statistical analysis The paired Student's t test was used for statistical
evaluation, a level p < 0.05 being taken as signi®cant. The signi®cance
of the correlation between the Candida albicans cell counts and the
colony forming units was determined by analysis of variance.
RESULTS
Spontaneous and stimulated human keratinocyte Candida
albicans killing is inhibited by mannan and Man-BSA but not
by Gal-BSA The spontaneous Candida killing activity of freshly
separated keratinocytes was decreased by more than 50% by
mannan at both 100 mg per ml and 500 mg per ml concentrations,
indicating a potent inhibitory activity (Fig 1a). Pretreatment with
a-MSH, IL-8, or UVB light induced a nearly 3-fold increase in the
Candida killing activity of epidermal cells. Incubation with mannan
resulted in a signi®cant reduction in the percentage of all stimulated
Candida. The mannan inhibition of the stimulated killing activity
was higher at 500 mg per ml than at 100 mg per ml mannan
concentration. The presence of 100 mg per ml or 500 mg per ml
Man-BSA inhibited the spontaneous killing activity very similarly
to mannan (Fig 1b), but Man-BSA exhibited a higher inhibition
than mannan at the corresponding concentrations of the activated
killing. Our results are analogous to those obtained in experiments
with macrophages (Marodi et al, 1994). The spontaneous Candida
killing activity of freshly separated keratinocytes was not in¯uenced
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by the addition of Gal-BSA, suggesting that the inhibitory effect of
mannan was speci®c (9.7 6 1.2% and 9.3 6 2.3% Candida cell
death, respectively, in the presence or absence of 300 mg per ml
Gal-BSA). Data were obtained from two independent experiments
performed in triplicate.
Mannan did not exert a non-speci®c protective effect on
ciclopirox-olamine-induced Candida albicans cell death. The addi-
tion of 5 mg per ml ciclopirox olamine killed the total number of
Candida cells both in the presence and in the absence of mannan. In
the presence of mannan 6.3 6 0.6%, and in the absence of mannan
6.7 6 0.6%, of yeast cells were killed by 2.5 mg per ml ciclopirox
olamine. These results were obtained from two independent
experiments performed in triplicate.
To probe the hypothesis that Man-BSA may interfere with the
killing of Candida by cells that do not express mannose-binding
receptors, we studied the killing of Candida albicans by peripheral
blood granulocytes. There was no difference in the killing of
Candida albicans opsonized with 2.5% normal human serum in the
presence or absence of Man-BSA (45 6 7% and 39 6 5%,
respectively, in the presence or absence of 1 mg per ml Man-BSA
after a 30 min incubation). These data were obtained from four
independent experiments performed in triplicate.
Candida albicans adheres to human keratinocytes and this
adherence is inhibited by mannan To visualize the
adherence of Candida albicans to keratinocytes, FITC-conjugated
yeast cells were incubated with keratinocytes. Figure 2(a) shows
that FITC-positive Candida cells attached to the surface of
keratinocytes. The addition of 3 mg per ml mannan produced a
signi®cant decrease in the number of keratinocytes that bound
FITC-conjugated Candida (Fig 2b). Candida adherence was
quantitated by means of ¯ow cytometric analysis. Unattached
FITC-labeled Candida cells were electronically gated out on the
basis of light scattering analysis. After a 120 min incubation 16% of
the keratinocytes were FITC-positive, indicating the adherence of
the yeasts to the keratinocytes (Fig 2c). Following mannan
pretreatment of human keratinocytes for 60 min prior to
incubation with Candida albicans, 6% of keratinocytes were
FITC-positive, revealing a marked decrease in their Candida-
binding capacity (Fig 2d).
Immunohistology of human skin sections The monoclonal
antibody speci®c for human MMR (Lew et al, 1994) showed clear
staining of individual cells in the dermis, whereas no positive cells
were seen in the epidermis (Fig 3a). The polyclonal antibody raised
against human MMR displayed a similar staining pattern in the
dermis, but it also showed the staining of keratinocytes, which was
more pronounced, affecting cells in the suprabasal layers (Fig 3b).
With both controls, weak, diffuse, cytoplasmic staining was
observed throughout the epidermis and dermis (not shown),
indicating that the antibody staining was speci®c. These results
suggest that the KcMR differs from the MMR.
Isolation of KcMR To further characterize the KcMR, a
human keratinocyte extract was subjected to mannose±Sepharose
af®nity chromatography. Gel electrophoresis of the eluted protein
revealed a single band at ~200 kDa (Fig 4). The human MMR has
a molecular weight of around 175 kDa.
Western blotting On Western blots of human keratinocyte
and HaCaT cell extracts, the polyclonal goat anti-human MMR
antibody stained a band with a molecular weight of approximately
200 kDa (Fig 5).
125I-Man-BSA binding to freshly separated human keratino-
cytes Radioligand binding experiments were performed with
125I-Man-BSA (63104 cpm per well) at 4°C to prevent
internalization and degradation of the ligand. Competition studies
revealed that unlabeled mannan dose-dependently inhibited 125I-
Man-BSA binding to freshly separated human keratinocytes,
suggesting that 125I-Man-BSA binding to the cells was mannan-
speci®c (Fig 6).
Incubation of keratinocytes with increasing concentrations of
125I-Man-BSA resulted in increasing ligand binding to the cells
(Fig 7). Analysis of the binding data via a nonlinear curve-®tting
program (MxN-FIT) indicated a single class of mannose-binding
sites with a KD of 1.4 3 10
±8 M and a Bmax of 1 3 10
4 binding sites
per cell. The Scatchard transformation of the data was linear,
suggesting a single population of receptors (Fig 7, inset).
Internalization of 125I-Man-BSA In separate experiments,
keratinocytes were incubated with 4 3 106 cpm per well of 125I-
Man-BSA, with or without 3 mg per ml mannan, at 37°C for 10,
20, or 30 min. The mannan-speci®c binding was calculated by
subtracting the measured radioactivity in the presence of mannan
(mannan-independent binding) from the radioactivity measured in
the absence of mannan (total binding) (Fig 8). The mannan-
independent binding detected after a 10 min incubation at 37°C
did not vary considerably on further incubation (20, 30 min),
whereas the mannan-speci®c binding increased on longer
incubation. After a 10 min incubation there was no difference in
acid-labile and acid-stable speci®c radioactivity (Fig 9). After 30
min incubation the considerable increase (8-fold) in mannan-
speci®c binding was acid-precipitable to almost 90%, whereas the
acid-stable fraction exhibited only a slight change. This suggested
Figure 1. Mannan and Man-BSA inhibit Candida killing by
keratinocytes. (a) Mannan, (b) Man-BSA. Spontaneous and stimulated
(a-MSH, IL-8, and UVB) Candida killing is represented by gray bars.
Addition of 100 mg per ml mannan or 100 mg per ml Man-BSA (white
bars) or 500 mg per ml mannan or 500 mg per ml Man-BSA (black bars)
to the killing assay resulted in a signi®cant reduction of both the
spontaneous and the stimulated Candida albicans killing. Error bars
represent the means 6 SEM of the results of six separate experiments.
Candida killing activity is expressed as the percentage of killed yeast cells.
An asterisk denotes signi®cant difference (p < 0.05).
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that most of the bound 125I-Man-BSA remained cell-surface-
associated and only a very small portion was internalized.
Effect of Ca2+ depletion on radioligand binding To
determine the Ca2+ dependence of carbohydrate recognition, we
examined the effect of EGTA, a Ca2+-chelating agent, on the
ligand binding. In the radioligand binding assay, human
keratinocytes (5 3 105) were incubated with 125I-Man-BSA (4
3 106 cpm per well) in the presence or absence of 10 mM EGTA
for 30 min at 37°C. As shown in Fig 10, EGTA almost completely
inhibited the radioligand binding to the keratinocytes, suggesting
that the binding was Ca2+-sensitive.
Effect of trypsin on 125I-Man-BSA binding The trypsin
sensitivity of the mannose-binding sites was investigated by
incubating the freshly separated human keratinocytes with 10 mg
per ml of trypsin at 37°C for different time intervals prior to the
radioligand binding study. In line with previous observations
involving the use of macrophages (Stahl, 1990), the binding sites
appeared to be highly sensitive to trypsin treatment. Trypsin
induced a time-dependent loss of radioligand binding (Fig 11).
Incubation of cells with trypsin for 120 min resulted in a loss of
>90% of the radioligand binding.
Flow cytometric analysis of KcMR Although the keratino-
cytes were exposed to trypsin during cell preparation in our
Candida killing and 125I-Man-BSA binding assays, the results of the
experiments indicated that the receptors recovered quickly. Kang
and Schlesinger also found that the removal of surface-expressed
MMR activity by trypsin incubation at 4°C was followed by a fast
(10 min) recovery of the receptor activity at 37°C (Kang and
Schlesinger, 1998). To determine the recovery of the KcMR after
trypsinization during the preparation of a cell suspension, freshly
separated keratinocytes were incubated in PBS at 37°C for 10, 30,
60, or 120 min after trypsin exposure, and then stained with the
goat polyclonal serum and analyzed by ¯ow cytometry. Both the
Figure 3. Sections of normal human skin
stained with antibodies against the human
MMR. With the monoclonal antibody (mAb15) a
few individual cells showed positive staining in
the dermis (arrow) (a). The polyclonal antibody
stained not only the dermal cells but also the
keratinocytes in the epidermis (b). The staining
was more pronounced on the suprabasal cells and
the pattern indicated a membrane localization.
Scale bar: 20 mm.
Figure 2. Candida albicans adheres to the
surface of keratinocytes. Fluorescence micro-
scopy analysis demonstrated that keratinocytes
with moderate auto¯uorescence bound FITC-
conjugated, round-shaped intensely ¯uorescing
Candida cells following a 120 min incubation
(arrow) (a). Incubation with 3 mg per ml mannan
reduced the number of keratinocytes that bound
Candida (b). Candida attachment was quantitated
by ¯ow cytometry (c, d). Non-adherent Candida
cells were gated out on the basis of their light-
scatter characteristics. The abscissa depicts yeast
cell ¯uorescence intensity on a logarithmic scale
and the ordinate gives the relative cell number.
(A) Auto¯uorescence of keratinocytes without
FITC-labeled yeasts; (B) ¯uorescence of Candida
cells adhered to the surface of keratinocytes.
FITC-conjugated Candida albicans cells were
incubated with freshly separated keratinocytes for
120 min. After the incubation 16% of the
keratinocytes were FITC-positive, indicating the
adherence of the yeasts to the keratinocytes (c).
Following mannan (3 mg per ml) pretreatment of
human keratinocytes for 60 min prior to
incubation with Candida albicans, 6% of
keratinocytes were FITC-positive (d).
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percentage of positive cells and DMCF (the mean channel
¯uorescence of cells stained with the goat immune serum minus
the mean channel ¯uorescence of cells stained with the non-
immune goat serum) showed a rapid, time-dependent increase in
KcMR re-expression on keratinocytes. After the shortest (10 min)
incubation, 32.5% of the cells already exhibited positive staining
relative to the isotype control, and the DMCF was 8.36 (Fig 12),
indicating that KcMR on the keratinocytes can recover very
rapidly after trypsinization. Following prolonged incubation, we
detected time-dependent increases in both the number of
mannose-receptor-positive cells (30 min, 49.38%; 60 min,
56.18%; 120 min, 65.81%) and DMCF (30 min, 12.47; 60 min,
14.08; 120 min, 17.05).
DISCUSSION
The mechanism of the host defense against pathogenic micro-
organisms in the skin is not completely understood. We demon-
strated earlier that human epidermal cells exert candidacidal activity
mediated by keratinocytes (Csato et al, 1986, 1987).
A plasma membrane receptor for ligands with terminal mannose
residues, the MMR, has already been well de®ned on human
macrophages (Stahl, 1990). Mannose receptors can mediate the
endocytotic clearance of glycoproteins, including enzymes from
neutrophils, tissue-type plasminogen activator, glucocerebrosidase,
Figure 6. Competition study of 125I-Man-BSA binding to human
keratinocytes. Cells were incubated at 4°C for 90 min with 125I-Man-
BSA (6 3 104 cpm per well) and with increasing concentrations of
unlabeled ligand (mannan) in the range 10±3000 mg per ml. Mannan
dose-dependently inhibited the 125I-Man-BSA binding to freshly
separated keratinocytes. Error bars represent the means 6 SEM of the
results of six separate experiments.
Figure 7. Saturation study of 125I-Man-BSA binding to human
keratinocytes. Cells were incubated with increasing concentrations of
125I-Man-BSA (105±2 3 106 cpm per well). Mannan-independent
binding was determined in the presence of 3 mg per ml unlabeled
mannan. Mannan-speci®c binding was de®ned as the difference between
the total and the mannan-independent 125I-Man-BSA binding. Each
assay was carried out in duplicate in three separate experiments. The inset
shows the Scatchard analysis of the data: KD = 1.4 3 10
±8 M, and Bmax
= 104 binding sites per cell.
Figure 8. Radioligand binding of human keratinocytes at 37°C.
The binding of 125I-Man-BSA (4 3 106 cpm in each well) was
measured at 37°C after 10, 20, or 30 min. The total binding was time-
dependent. The difference between the total (solid line) and the mannan-
independent activity (measured in the presence of 3 mg per ml unlabeled
mannan) (dashed line) is shown by the dotted curve and represents the
mannan-speci®c binding. Error bars are the means of the results of four
separate experiments 6 SEM.
Figure 4. SDS-PAGE of the human KcMR. The eluates with the
two highest protein contents (lanes 2 and 3) from epoxy-activated
mannose±Sepharose 6B column were concentrated and subjected to
SDS-PAGE under non-reducing conditions. Proteins were stained with
silver. The separation revealed a single protein with a mass of ~200 kDa
(arrow). Lane 1: molecular weight marker.
Figure 5. Western blotting of keratinocyte cell lysates. Human
keratinocyte (lane 1) and the human immortalized keratinocyte cell line
HaCaT (lane 2) cell extracts were blotted to nitrocellulose ®lter. The
arrow indicates the position of an ~200 kDa protein recognized by the
goat anti-human MMR antiserum. Lane 3: molecular weight marker.
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and ricin, and the uptake of IgE, and they are involved in the
phagocytosis of various microorganisms (Chung et al, 1984; Speert
et al, 1988; Rijken et al, 1990; Magnusson and Berg, 1993;
Richardson et al, 1993; Sato and Beutler, 1993). Marodi et al
reported that monocyte-derived macrophages are able to ingest and
kill Candida through the mannose receptor (Marodi et al, 1991a;
1991b). The expression of the surface MMR can be downregulated
during macrophage activation with Bacillus-Calmette-Guerin
(Ezekowitz et al, 1981) or with lipopolysaccharide and phorbol
esters (Shepherd et al, 1990), and upregulated by corticosteroids,
PGE2, and IL-4 (Schreiber et al, 1990; Stahl, 1990; Stein et al,
1992). Although interferon g (IFN-g) treatment decreases the
number of mannose receptors on the macrophages, their capacity
for mannose-receptor-mediated phagocytosis is increased, suggest-
ing a dissociation between the effects of IFN-g on the numbers of
receptors expressed on the surface and the function of these
receptors (Marodi et al, 1993; 1994).
In earlier studies, we have shown that Candida albicans killing by
human keratinocytes can be enhanced by UVB light, a-MSH
(Csato et al, 1987; 1989), and IL-8.1 This study has revealed that
mannan and Man-BSA are very effective inhibitors of both
spontaneous and UVB-, a-MSH-, and IL-8-stimulated Candida
killing by freshly separated keratinocytes, indicating that mannose-
binding structures are present on the keratinocytes and play a role
Figure 9. Binding of 125I-Man-BSA to human keratinocytes at
37°C is drastically decreased after acetic acid (pH 3) treatment.
The binding of 125I-Man-BSA at 37°C was also measured after a 3 min
treatment with acetic acid (pH 3). The mannan-speci®c binding,
calculated as the difference between the total and the mannan-
independent binding, is shown by the black bars. The mannan-speci®c
binding after acetic acid treatment is demonstrated by the gray bars (acid
stable). The difference between the total and the acid-stable binding
represents the acid-labile binding (white bars). Error bars are the means of
the results of four separate experiments 6 SEM.
Figure 10. Ca2+ depletion inhibits 125I-Man-BSA binding to
human keratinocytes. In the radioligand binding assay, human
keratinocytes were incubated with 125I-Man-BSA in the presence or
absence of 10 mM EGTA for 30 min at 37°C. The ®gure shows the
mannan-speci®c binding. Error bars represent means 6 SEM, n = 4; the
asterisk denotes a signi®cant decrease (p < 0.01) for cells treated with
EGTA compared with cells without EGTA treatment.
Figure 11. Limited proteolysis reduces 125I-Man-BSA binding to
human keratinocytes. Trypsin treatment at 37°C was used to assess the
sensitivity of the KcMR to proteolytic digestion. 125I-Man-BSA binding
was measured both in the presence and in the absence of mannan.
Incubations were stopped and binding was evaluated after an incubation
period of 0, 10, 60, or 120 min with 10 mg per ml trypsin. The
mannan-speci®c 125I-Man-BSA binding underwent signi®cant time-
dependent decrease. Error bars represent means 6 SEM, n = 4; the
asterisks denote signi®cant decreases (*p < 0.05 and **p < 0.001) on
trypsin-treated cells relative to cells without trypsin treatment.
Figure 12. Flow cytometric detection of human KcMR on freshly
separated human keratinocytes after trypsin treatment. Cells were
stained with the goat anti-human MMR antiserum and analyzed by ¯ow
cytometry. For isotype control, non-immune goat serum was used. Ten
minutes after the trypsin treatment 32.5% of the cells already exhibited
positive staining (FL1, thick line) relative to the isotype control (FL1, thin
line), and the DMCF was 8.36, indicating that the KcMR on the
keratinocytes can recover very rapidly after trypsinization.
1Kemeny L, Kenderessy AS, Arenberger P, Peter RU, Dobozy A,
Ruzicka A: Interleukin-8 induced chemotaxis and increased Candida
albicans killing activity of normal human epidermal cells. Arch Dermatol Res
284:26, 1992 (abstr.)
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in the killing. Gal-BSA did not have any in¯uence on the Candida
killing activity of freshly separated human keratinocytes, suggesting
that mannan and Man-BSA have speci®c inhibitory effects.
Pretreatment of Candida cells with mannan did not protect the
yeast from the fungicidal effect of the antimycotic drug ciclopirox
olamine, ruling out the possibility that mannan and Man-BSA
exerted a non-speci®c protective effect on Candida albicans cells,
making them more resistant to killing. Similarly, mannan did not
exert any in¯uence on the Candida killing activity of human PMN
leukocytes that lacked mannose receptor. These results con®rm that
mannan has a speci®c effect on the Candida±keratinocyte inter-
action. The adherence of Candida to keratinocytes was visualized
by ¯uorescence microscopy and ¯ow cytometric analysis. These
data proved that freshly separated human keratinocytes bind
¯uorescein-labeled Candida albicans cells on their surface, and this
can be inhibited by the addition of mannan. To characterize the
mannose-binding sites on the surface of the keratinocytes, we
performed radioligand binding assays with 125I-Man-BSA at 4°C.
Mannan exhibited a potent dose-dependent inhibitory effect on the
125I-Man-BSA binding of the keratinocytes. The binding assays
indicated that the number of binding sites per keratinocyte is
10.000 per cell with a KD of 1.4 3 10
±8 M. At 37°C, the trace-
labeled Man-BSA binding displayed a time-dependent increase and
the binding was again inhibited by mannan. The majority (nearly
90%) of the cell-bound 125I-Man-BSA was precipitable with acetic
acid, indicating that most of the Man-BSA remained on the surface
of the keratinocytes and only a small portion was internalized. The
depletion of Ca2+ decreased the Man-BSA binding capacity of the
keratinocytes. Proteolytic digestion with trypsin at 37°C consid-
erably reduced the binding activity, but removal of the surface
receptors with trypsin was followed by a rapid recovery.
Characteristic features of the mannose-binding structures of
keratinocytes are compared with the characteristics of the MMR in
Table I. These two structures exhibit similarities in the number of
binding sites per cell, in the dissociation constants, in their
sensitivity to proteolysis, and in their Ca2+-dependent activity.
Macrophages internalize mannose ef®ciently, but a similar
phenomenon cannot be observed with keratinocytes. Whereas a
monoclonal antibody against MMR did not stain keratinocytes, a
goat anti-human MMR immune serum reacted with suprabasally
localized keratinocyte membrane structures. Mannose±Sepharose
chromatography of keratinocyte extracts isolated a single protein
with an apparent molecular weight of ~200 kDa, and on Western
blot, the goat anti-human MMR immune serum also recognized a
band of around 200 kDa. The human MMR has a molecular
weight around 175 kDa. These data indicate that the mannose-
binding receptors on human keratinocytes could be different from
the human MMR.
The ability of mannose binding is shared by a number of
different Ca2+-dependent (type C) lectins (Weis et al, 1998).
Whereas most of the members of the type C lectin group contain
only a single carbohydrate-binding domain (Mullin et al, 1994), the
known receptors have either 8 (MMR and phospholipase A2
receptor) or 10 (DEC 205 receptor) lectin domains, and it is likely
that these domains cooperate with each other to enhance ligand
avidity (Ezekowitz et al, 1991; Taylor et al, 1992). All three of these
receptors appear to mediate various endocytotic phenomena
(Harris et al, 1992; Jiang et al, 1995; Zvaritch et al, 1996). Our
results indicate that the KcMR is probably not a member of the
endocytotic type C lectins. Although our data clearly suggest that
the KcMR plays a role in the Candida killing activity of the cells, in
light of the differences between the MMR and the KcMR the
mechanism of killing may be different.
Our data indicate that the human KcMR is responsible for the
initial phase of anti-Candida activity. Various effector mechanisms
can restrict Candida growth in infected hosts. We have recently
demonstrated that nitric oxide (NO) plays a crucial role in the
Candida killing mechanism of keratinocytes.2 The adherence of
Candida cells to the KcMR could induce NO production.
Numerous studies have reported that NO synthesis is a necessary
component of non-speci®c defense mechanisms against various
bacteria, viruses, and fungi (Liew and Cox, 1991). Human
keratinocytes are sources of constitutive and inducible NO
isoforms. It has been shown that IL-8, a-MSH, and UVB
irradiation can induce NO production by keratinocytes (Bruch-
Gerharz et al, 1996; 1998). Several pathogens, such as Escherichia coli,
Candida albicans, and Mycobacteria, have been shown to be sensitive
to NO, and the chemical generation of NO on the skin surface may
provide a protective mechanism against various pathogens (Fierro
et al, 1996). NO synthesis could be mediated through MMR in
chicken (Karaca et al, 1995). Mannose receptors may also be
involved in the induction of human-beta-defensin-2 (hBD-2
peptide antibiotic), which is highly effective against Candida
albicans, Staphylococcus aureus, S. epidermidis, and Pseudomonas
aeruginosa (Harder et al, 1997). It has been observed that the
human skin contains a shield of endogenous peptide antibiotics
(Gallo and Huttner, 1998). Besides the constitutively expressed
antimicrobial peptides, a group of these proteins are inducible and
can be recruited by contact with microorganisms.
Our results reveal the presence and for the ®rst time the
physiologic importance in the host defense against Candida
infection of mannose receptors on human keratinocytes. Further
work is needed for a better characterization of their structure and
function.
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